Abstract
To the Editor: We wish to retract our letter to the editor, “Duration of Survival in Patients with Myeloma Treated with Thalidomide,” which was published in the Journal on July 10, 2008.1 The content of this letter, submitted in February 2008 and accepted by the Journal in March 2008, largely duplicates the data that were published online by Blood on May 20, 2008.2
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
